TCL Archive Orlando Health President Mark Rohl We Opted For A Florida-Centric Strategy January 10, 2014
TCL Archive Single-Agent Phase III Trial Comparing Vectibix to Erbitux Meets Primary Endpoint May 31, 2013
TCL Archive In Brief: NCI To Supply Maytansine For Several Phase I Studies; Holleb Urges Referrals To “Experts” March 26, 1976
TCL Archive ODAC Votes For Approval Of PegIntron For Melanoma, Votrient For Renal Cancer October 9, 2009
